substance p has been researched along with Diabetes Mellitus, Type 1 in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (4.17) | 18.7374 |
1990's | 6 (25.00) | 18.2507 |
2000's | 10 (41.67) | 29.6817 |
2010's | 5 (20.83) | 24.3611 |
2020's | 2 (8.33) | 2.80 |
Authors | Studies |
---|---|
Chen, W; Jia, Y; Liang, C; Luo, H; Quan, X; Wang, J; Wang, Y | 1 |
Issar, T; Krishnan, AV; Kwai, N; Markoulli, M; Pisarcikova, J; Poynten, AM; Tummanapalli, SS; Willcox, MDP | 1 |
Byeon, Y; Dubon, MJ; Jung, N; Kim, D; Kim, DY; Park, KS; Son, Y; Um, J | 1 |
Karamichos, D; Ma, JX; Priyadarsini, S; Rowsey, TG | 1 |
Choi, S; Jung, N; Kim, D; Lee, SH; Park, KS; Son, Y; Um, J | 1 |
Danielson, P; Di, G; Duan, H; Qi, X; Qu, M; Wang, Y; Xie, L; Yang, L; Zhou, Q | 1 |
Aust, W; Fitzl, G; Löster, H; Schneider, R; Welt, K | 1 |
Bosch, F; De Giorgio, R; Domènech, A; Gori, A; Jiménez, M; Pasquinelli, G; Pumarola, M | 1 |
Forsgren, S; Holmberg, D; Lejon, K; Persson-Sjögren, S | 1 |
Kamiya, H; Sima, AA; Zhangm, W | 1 |
Kamiya, H; Sima, AA; Zhang, W | 1 |
Ekberg, K; Kamiya, H; Sima, AA; Wahren, J; Zhang, W | 1 |
Afifiyan, FN; Chan, Y; Dosch, HM; Driver, JP; Liu, XJ; Razavi, R; Salter, MW; Santamaria, P; Serreze, D; Tang, L; Tsai, S; Tsui, H; Wan, X; Yantha, J | 1 |
Hikawa, N; Horie, H; Inoue, S; Sango, K; Sotelo, JR; Takenaka, T; Tanaka, S; Verdes, JM | 1 |
Beyer, LA; Kamijo, M; Kojima, Y; Owyang, C; Sima, AA; Takahashi, T; Tsunoda, Y | 1 |
El-Salhy, M; Spångéus, A | 1 |
Ouyang, A; Yu, O | 1 |
Allard, S; Chowienczyk, PJ; Cummings, MH; Meeking, DR; Munday, J; Shaw, KM | 1 |
Beyer, J; Engelbach, M; Forst, T; Goitom, K; Harzer, O; Kunt, T; Löbig, M; Pfützner, A; Pohlmann, T; Schmidt, S; Schneider, S | 1 |
El-Salhy, M; Forsgren, S; Spångéus, A | 1 |
Horvath, P; Kovács, P; Németh, J; Sziklai, I; Szilasi, M; Szilvássy, J; Szilvássy, Z | 1 |
Dorsey, DA; Roth, KA; Schmidt, RE | 1 |
Boolell, M; Tooke, JE | 1 |
Christensen, NJ; Fahrenkrug, J; Henriksen, JH; Kastrup, J; Parving, HH; Pedersen, JH; Schaffalitzky de Muckadell, OB; Schwartz, T | 1 |
24 other study(ies) available for substance p and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Downregulation of BDNF-TrkB signaling may contribute to the colonic motility disorders in mice with streptozocin-induced diabetes.
Topics: Animals; Brain-Derived Neurotrophic Factor; Colonic Diseases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Down-Regulation; Mice; Streptozocin; Substance P | 2023 |
A Comparative Study on the Diagnostic Utility of Corneal Confocal Microscopy and Tear Neuromediator Levels in Diabetic Peripheral Neuropathy.
Topics: Adult; Area Under Curve; Calcitonin Gene-Related Peptide; Cornea; Corneal Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Microscopy, Confocal; Middle Aged; Prospective Studies; ROC Curve; Substance P; Tears; Trigeminal Nerve Diseases | 2020 |
Substance P preserves pancreatic β-cells in streptozotocin-induced type 1 diabetic mice.
Topics: Acute Disease; Animals; Apoptosis; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Pancreatitis; Streptozocin; Structure-Activity Relationship; Substance P | 2017 |
Unravelling the stromal-nerve interactions in the human diabetic cornea.
Topics: Biomarkers; Case-Control Studies; Cell Differentiation; Cells, Cultured; Coculture Techniques; Collagen; Corneal Diseases; Corneal Stroma; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Extracellular Matrix; Female; Fibroblasts; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Models, Biological; Neurons; Receptor, IGF Type 1; Substance P; Tubulin | 2017 |
Substance P preserves pancreatic β-cells in type 1 and type 2 diabetic mice.
Topics: Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Hyperglycemia; Immunomodulation; Insulin-Secreting Cells; Male; Mice, Inbred NOD; Pancreatic Stellate Cells; Substance P | 2018 |
Substance P promotes diabetic corneal epithelial wound healing through molecular mechanisms mediated via the neurokinin-1 receptor.
Topics: Animals; Cell Line; Cornea; Corneal Injuries; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Epithelial Cells; ErbB Receptors; Hyperglycemia; Male; Mice; Mice, Inbred C57BL; Mitochondria; Neurotransmitter Agents; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Receptors, Neurokinin-1; Sirtuin 1; Substance P; Touch; Wound Healing | 2014 |
Cardiac ischemia and reperfusion in spontaneously diabetic rats with and without application of EGb 761: II. Interstitium and microvasculature.
Topics: Animals; Cardiovascular Agents; Collagen; Diabetes Complications; Diabetes Mellitus, Type 1; Free Radical Scavengers; Ginkgo biloba; Immunohistochemistry; Male; Microcirculation; Microscopy, Electron, Transmission; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide Synthase Type III; Phytotherapy; Plant Extracts; Rats; Rats, Inbred BB; Substance P | 2009 |
Morphofunctional changes underlying intestinal dysmotility in diabetic RIP-I/hIFNβ transgenic mice.
Topics: Animals; Choline O-Acetyltransferase; Colon; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Disease Models, Animal; Gastric Emptying; Gastrointestinal Motility; Ileum; Interferon-beta; Male; Mice; Mice, Transgenic; Myenteric Plexus; Nitric Oxide Synthase Type I; Receptor-Interacting Protein Serine-Threonine Kinases; Streptozocin; Substance P; Vasoactive Intestinal Peptide | 2011 |
Expression of the NK-1 receptor on islet cells and invading immune cells in the non-obese diabetic mouse.
Topics: Animals; Diabetes Mellitus, Type 1; Gene Expression Regulation; Islets of Langerhans; Leukocytes; Mice; Mice, Inbred NOD; Receptors, Neurokinin-1; Substance P | 2005 |
Apoptotic stress is counterbalanced by survival elements preventing programmed cell death of dorsal root ganglions in subacute type 1 diabetic BB/Wor rats.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Calcitonin Gene-Related Peptide; Caspases; Diabetes Mellitus, Type 1; Ganglia, Spinal; Gene Expression Regulation, Enzymologic; Heat-Shock Proteins; Neurons; Rats; Rats, Inbred BB; Rats, Inbred Strains; Receptors, Nerve Growth Factor; Substance P | 2005 |
Degeneration of the Golgi and neuronal loss in dorsal root ganglia in diabetic BioBreeding/Worcester rats.
Topics: Animals; Axons; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Ganglia, Spinal; Golgi Apparatus; Hindlimb; Hot Temperature; Nerve Growth Factors; Neurons; Prediabetic State; Rats; Rats, Inbred BB; Receptor, IGF Type 1; Receptor, Insulin; Sciatic Nerve; Substance P | 2006 |
C-Peptide reverses nociceptive neuropathy in type 1 diabetes.
Topics: Animals; C-Peptide; Calcitonin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Ganglia, Spinal; Male; Nerve Fibers; Nerve Regeneration; Neuritis; Neurons; Rats; Rats, Inbred BB; Reference Values; Substance P | 2006 |
TRPV1+ sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes.
Topics: Animals; Autoimmunity; Capsaicin; Diabetes Mellitus, Type 1; Female; Inflammation; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans; Male; Mice; Mice, Congenic; Mice, Inbred C57BL; Mice, Inbred NOD; Neurons, Afferent; Substance P; T-Lymphocytes; TRPV Cation Channels | 2006 |
Nerve growth factor (NGF) restores depletions of calcitonin gene-related peptide and substance P in sensory neurons from diabetic mice in vitro.
Topics: Animals; Calcitonin Gene-Related Peptide; Cell Survival; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; Ganglia, Spinal; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Nerve Growth Factors; Nerve Tissue Proteins; Neurons, Afferent; Streptozocin; Substance P | 1994 |
Impaired intracellular signal transduction in gastric smooth muscle of diabetic BB/W rats.
Topics: Acetylcholine; Animals; Calcium; Carbachol; Cell Membrane; Cells, Cultured; Cytosol; Diabetes Mellitus, Type 1; Electric Stimulation; Humans; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Male; Muscle Contraction; Muscle, Smooth; Potassium Chloride; Protein Kinase C; Rats; Rats, Inbred BB; Reference Values; Signal Transduction; Sodium Fluoride; Stomach; Substance P; Tetradecanoylphorbol Acetate | 1996 |
Substance P in the gastrointestinal tract of non-obese diabetic mice.
Topics: Animals; Diabetes Mellitus, Type 1; Digestive System; Enteric Nervous System; Female; Gastrointestinal Motility; Humans; Immunohistochemistry; Mice; Mice, Inbred NOD; Radioimmunoassay; Substance P | 1998 |
Substance P binding in gastrointestinal tract of nondiabetic BB rat and changes in diabetic BB rat over time.
Topics: Animals; Autoradiography; Diabetes Mellitus, Type 1; Digestive System; Disease Models, Animal; Gastrointestinal Motility; Male; Rats; Rats, Inbred BB; Receptors, Neurokinin-1; Substance P; Time Factors | 1999 |
Comparison of vasodilator effects of substance P in human forearm vessels of normoalbuminuric Type 1 diabetic and non-diabetic subjects.
Topics: Acetylcholine; Albuminuria; Blood Flow Velocity; Diabetes Mellitus, Type 1; Female; Forearm; Glycated Hemoglobin; Humans; Male; Nitroprusside; Substance P; Vasodilator Agents | 2000 |
Serum levels of substance P are decreased in patients with type 1 diabetes.
Topics: Adolescent; Adult; Aged; Cholesterol; Diabetes Mellitus, Type 1; Female; Humans; Immunoenzyme Techniques; Male; Middle Aged; Reference Values; Substance P | 2000 |
Effect of diabetic state on co-localization of substance P and serotonin in the gut in animal models.
Topics: Animals; Colon; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Digestive System; Duodenum; Enteroendocrine Cells; Female; Image Processing, Computer-Assisted; Immunohistochemistry; Intestinal Mucosa; Male; Mice; Mice, Inbred NOD; Mice, Obese; Prediabetic State; Pyloric Antrum; Serotonin; Substance P | 2001 |
Feeble bronchomotor responses in diabetic rats in association with decreased sensory neuropeptide release.
Topics: Animals; Blood Glucose; Body Weight; Bronchial Hyperreactivity; Bronchoconstriction; Calcitonin Gene-Related Peptide; Capsaicin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Guinea Pigs; Insulin; Male; Neural Conduction; Neurons, Afferent; Ovalbumin; Rats; Rats, Wistar; Somatostatin; Substance P; Trachea | 2002 |
Immunohistochemical characterization of NPY and substance P containing nerve terminals in aged and diabetic human sympathetic ganglia.
Topics: Aged; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Ganglia, Sympathetic; Humans; Immunohistochemistry; Nerve Endings; Neurons; Neuropeptide Y; Substance P | 1992 |
The skin hyperaemic response to local injection of substance P and capsaicin in diabetes mellitus.
Topics: Adult; Capsaicin; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Female; Humans; Injections, Intradermal; Male; Reference Values; Regional Blood Flow; Skin; Substance P; Ultrasonography | 1990 |
Effect of ganglionic blockade on endogenous circulating pancreatic polypeptide, vasoactive intestinal polypeptide, substance P, neurotensin and noradrenaline in healthy controls and long-term insulin-dependent diabetic patients.
Topics: Adult; Autonomic Nervous System; Autonomic Nervous System Diseases; Diabetes Mellitus, Type 1; Female; Humans; Male; Neurotensin; Norepinephrine; Pancreatic Polypeptide; Peptides; Substance P; Trimethaphan; Vasoactive Intestinal Peptide | 1986 |